|
ELECTRONIC POSTERS |
|
|
Session Name |
Abstract Numbers |
Day |
|
Vascular Hemodynamics |
2825 - 2832
|
Monday |
|
Vessel Compliance |
2833 - 2836 |
Monday |
|
Myocardial T2 & T2* Imaging |
2837 - 2840 |
Monday |
|
Vessel Wall Imaging |
2841 - 2856 |
Monday |
|
Cardiac Image Processing |
2857 - 2864 |
Tuesday |
|
MRA - Other Techniques |
2865 - 2868 |
Tuesday |
|
Time-resolved (YD) MRA |
2869 - 2880 |
Tuesday |
|
Animal Cardiovascular Imaging |
2881 - 2889 |
Tuesday |
|
Non-Contrast Enhanced MRA |
2890 - 2909 |
Wednesday |
|
Myocardial Function: Human Studies |
2910 - 2917 |
Wednesday |
|
MRA Contrast Agents |
2918 - 2921 |
Wednesday |
|
Coronary MRA |
2922 - 2929 |
Thursday |
|
Contrast-Enhanced Myocardial Perfusion
Imaging |
2930 - 2941 |
Thursday |
|
Cardiac Diffusion Tensor Imaging |
2942 - 2945 |
Thursday |
|
Myocardial Viability |
2946 - 2961 |
Thursday |
|
Safety: Acoustic Noise |
2962 - 2965 |
Monday |
|
Safety: Implants & Devices |
2966 - 2969 |
Tuesday |
|
RF Receive Coils |
2970 - 2977 |
Wednesday |
|
RF Transmit Coils & Calculations |
2978 - 2981 |
Wednesday |
|
RF Receive Coils: Dual Tuned & Microstrip |
2982 - 2985 |
Wednesday |
|
Systems, Subsystems & Hybrid Systems |
2986 - 2993 |
Thursday |
|
MR-Guided Interventions
(Non-Thermotherapy) |
2994 - 3009 |
Monday |
|
Thermal Therapy & HIFU |
3010 - 3025 |
Tuesday |
|
B0 Shimming |
3026 - 3029 |
Monday |
|
Artifact Reduction/Correction |
3030 - 3037 |
Monday |
|
Image Analysis - Parametric Mapping |
3038 - 3057 |
Monday |
|
Pulse Sequences |
3058 - 3061 |
Tuesday |
|
New Contrasts & Quantitation |
3062 - 3085 |
Tuesday |
|
Shared Resources & Quality Control |
3086 - 3089 |
Tuesday |
|
B1 Mapping |
3090 - 3093 |
Tuesday |
|
Image Registration & Alignment |
3094 - 3109 |
Wednesday |
|
Motion Artifact Correction |
3110 - 3133 |
Wednesday |
|
RF Pulse Design |
3134 - 3145 |
Thursday |
|
Post-Nyquist Imaging |
3146 - 3157 |
Thursday |
|
Image Segmentation |
3158 - 3173 |
Thursday |
|
Spectroscopy Localization, Quantitation &
Methodology |
3174 - 3189 |
Monday |
|
Hyperpolarized 13C & Other Nuclei |
3190 - 3201 |
Monday |
|
Molecular Imaging Agents & Techniques |
3202 - 3217 |
Tuesday |
|
MRS of Cells, Body Fluids |
3218 - 3221 |
Wednesday |
|
Cell Labelling & Tracking |
3222 - 3237 |
Wednesday |
|
MRS Methodology |
3238 - 3249 |
Thursday |
|
Non-Proton MRI |
3250 - 3257 |
Thursday |
|
Measurement of Perfusion & Permeability
Using Contrast Agents |
3258 - 3265 |
Monday |
|
DTI of the Damaged Brain |
3266 - 3268 |
Monday |
|
Diffusion Modeling |
3269 - 3277 |
Monday |
|
MRI & MRS of Cerebral Ischemia |
3278 - 3299 |
Tuesday |
|
Diffusion: Artifacts, Phantoms, QA,
Reproducibility |
3300 - 3307 |
Tuesday |
|
Fiber Tracking & Connectivity Mapping |
3308 - 3319
|
Wednesday |
|
Crossing Fibers & Non-Tensor Approaches |
3320 - 3331 |
Wednesday |
|
Restricted
Diffusion |
3332 -
3337 |
Wednesday |
|
Methods for Brain Arterial Spin Labelling |
3338 - 3349 |
Thursday |
|
Diffusion
Acquisition |
3350 - 3362 |
Thursday |
|
Cerebral Perfusion & Diffusion Imaging of Animal Models |
3363 - 3377 |
Thursday |
|
Fetus & Neonate: Normal, Injury, Animal, Human |
3378
-3391 |
Monday |
|
Optic Nerve |
3392 -
3394 |
Monday |
|
Advanced
Spinal Cord Imaging |
3395 - 3406 |
Monday |
|
Spectroscopy & Computer Aided Analysis of Brain Tumor |
3407 - 3415 |
Monday |
|
MRA & Flow of Neurovascular Diseases |
3416 -
3427 |
Tuesday |
|
Multiple Sclerosis: Disease Severity, Progression |
3428 - 3447
|
Tuesday |
|
Prion Disease & Neurodegenerative Disorders |
3448 - 3455 |
Tuesday |
|
Pediatric Brain: DTI, Structural |
3456 - 3460 |
Tuesday |
|
MRI: ENT Imaging |
3461 - 3470
|
Wednesday |
|
MRI & MRS of Epilepsy |
3471 - 3479
|
Wednesday |
|
Brain Tumor: Perfusion & Diffusion & fMRI |
3480 - 3497
|
Wednesday |
|
Innovative Neuroimaging Sequences &
Applications I |
3498 - 3509 |
Wednesday |
|
Innovative Neuroimaging Sequences &
Applications II |
3510 - 3525 |
Thursday |
|
Alzheimer's Disease, Dementia, Age
|
3524 - 3545 |
Thursday |
|
Psychiatric MRI/MRS |
3546 - 3560 |
Thursday |
|
fMRI: Acquisition Methods |
3561 - 3570 |
Monday |
|
fMRI: Animal Models |
3571 - 3574 |
Monday |
|
fMRI: Non-BOLD & MT |
3575 - 3582 |
Tuesday |
|
fMRI: Neuroscience |
3583 - 3594 |
Tuesday |
|
fMRI: Connectivity & Networks |
3595 - 3606 |
Wednesday |
|
fMRI: ICA & Clustering Analysis |
3607 - 3610 |
Wednesday |
|
fMRI: Mechanisms |
3611 - 3618 |
Thursday |
|
fMRI: Multimodal & Single Trial |
3619 - 3626 |
Thursday |
|
Bone |
3627 - 3634 |
Monday |
|
Spine |
3635 - 3638 |
Monday |
|
Ultra-Short TE MRI in Musculoskeletal
Imaging |
3639 - 3642 |
Tuesday |
|
Small Animal Musculoskeletal Imaging |
3643 - 3646 |
Tuesday |
|
Cartilage |
3647 - 3662 |
Wednesday |
|
Musculoskeletal Miscellaneous |
3663 - 3670 |
Thursday |
|
Muscle |
3671 - 3678 |
Thursday |
|
Renal Parenchyma & Perfusion |
3679 - 3686 |
Monday |
|
Hyperpolarized Gas Lung MRI |
3687 - 3690 |
Monday |
|
Bowel Imaging |
3691 - 3694
|
Monday |
|
Body Diffusion & Whole Body Imaging |
3695 - 3698 |
Monday |
|
Iron Effects in Hepatic Imaging |
3699 - 3702 |
Monday |
|
Hepatobiliary |
3703 - 3730 |
Tuesday |
|
Advances in GE & Hepatobiliary Imaging |
3731 - 3742 |
Tuesday |
|
Perfusion of the Liver & Pancreas |
3743 - 3746 |
Wednesday |
|
Female Pelvis & Fetal Imaging |
3747 - 3750 |
Wednesday |
|
Breast MRI |
3751 - 3774 |
Wednesday |
|
Lung MRI |
3775 - 3790 |
Thursday |
|
Metabolism - Clinical Studies |
3791 - 3798 |
Thursday |
|
Prostate Cancer |
3799 - 3810 |
Monday |
|
Advances in Tumor MRS |
3811 - 3814 |
Monday |
|
Advances in Tumor MRI |
3815 - 3822 |
Tuesday |
|
Tumor Perfusion & Permeability |
3823 - 3838 |
Wednesday |
|
Gynecological Cancer |
3839 - 3846 |
Thursday |
|
Tumor Assessment & Response |
3847 - 3854
|
Thursday |